O. Novoplansky

EGFR overexpression increases radiotherapy response in HPV-Positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.

M. Elkabets, M. Tavassoli, B. Ayaz, 2020, Cancer letters.

Worldwide Prevalence and Clinical Characteristics of RAS Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis

M. Elkabets, S. Jagadeeshan, I. Menashe, 2022, Frontiers in Oncology.

in through

M. Tavassoli, B. Ayaz, S. Thavaraj, 2012 .

The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment

A. Porgador, M. Elkabets, R. Gazit, 2022, International journal of molecular sciences.

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

M. Elkabets, S. Jagadeeshan, E. Khrameeva, 2020, Cancers.

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Y. Carmi, A. Mock, J. Hess, 2021, Journal for ImmunoTherapy of Cancer.

Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs

Ilan Y. Smoly, Chanan M. Argov, C. Keasar, 2021, Proceedings of the National Academy of Sciences.

MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer

J. Baselga, N. Katabi, Raphael A. Pelossof, 2019, International journal of cancer.

Ubiquitin Accumulation on Disease Associated Protein Aggregates Is Correlated with Nuclear Ubiquitin Depletion, Histone De-Ubiquitination and Impaired DNA Damage Response

M. Goldberg, R. Kopito, M. Brandeis, 2017, PloS one.